Alvotech (ALVO) Total Non-Current Liabilities (2020 - 2026)

Alvotech (ALVO) posted Total Non-Current Liabilities of $1.4 billion for Q1 2026, down 1.62% on a QoQ basis from $1.5 billion in Q4 2025, and little changed year-over-year from $1.4 billion in Q1 2025.

Alvotech (ALVO) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Alvotech's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

  • Quarterly Total Non-Current Liabilities changed 0.2% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (changed 0.2% YoY) and the FY2025 annual result came in at $1.5 billion, up 1.86% from the prior year.
  • Total Non-Current Liabilities was $1.4 billion for Q1 2026 at Alvotech, down from $1.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.6 billion in Q4 2023 and bottomed at $471.9 million in Q2 2024.
  • A 5-year average of $1.3 billion and a median of $1.4 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities plunged 59.58% — and 2025, when it soared 172.57%.
  • Alvotech's Total Non-Current Liabilities stood at $1.2 billion in 2022, then surged by 32.32% to $1.6 billion in 2023, then decreased by 11.15% to $1.4 billion in 2024, then increased by 1.86% to $1.5 billion in 2025, then declined by 1.62% to $1.4 billion in 2026.
  • Business Quant data shows ALVO's Total Non-Current Liabilities at $1.4 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn 1.44 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.44 Bn
Dec 31, 2025 1.47 Bn
Sep 30, 2025 1.44 Bn
Jun 30, 2025 1.29 Bn
Mar 31, 2025 1.44 Bn
Dec 31, 2024 1.44 Bn
Sep 30, 2024 1.42 Bn
Jun 30, 2024 471.93 Mn
Mar 31, 2024 1.47 Bn
Dec 31, 2023 1.62 Bn
Jun 30, 2023 1.17 Bn
Mar 31, 2023 1.39 Bn
Dec 31, 2022 1.23 Bn
Jun 30, 2022 792.93 Mn
Dec 31, 2021 621.75 Mn
Dec 31, 2020 1.29 Bn